A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...